Q-Line Biotech Ltd.

•
₹ 549.757.37%

2026-08-21

qlinebiotech.comBSE: -NSE: QLINE
Market Cap₹ 1,204 Cr.
Current Price₹ 512
High / Low₹ 600 / 431
Stock P/E21.6
Book Value₹ 91
Price to Book5.64
Dividend Yield0.00 %
ROCE19.2 %
ROE13.9 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Manufacturing: 53.8% • Trading: 46.2%

PROS

    CONS

    • Receivables are growing faster than sales - a possible quality concern
    • Operating cash flow has been negative in recent years
    • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.01x)
    • Total debt has risen sharply - up 71.6% year on year
    • Free cash flow has been persistently negative

    * The pros and cons are machine generated based on quantitative rules.

    Peer comparison

    EDIT COLUMNS
    HealthcareHealthcareMedical Equipment/Supplies/Accessories
    Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
    S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
    1.LENSKART639.30169.67111193.840.002284.303634.3527141.801332.6912.5521.70
    2.POLYMED1771.6056.9917957.200.2085.27-8.39525.3830.3014.0524.11
    3.MOLBIO1040.3571.9711988.990.00————19.79—
    4.QLINE516.2021.611204.200.00————19.19—
    5.LAXMIDENTL195.6534.851076.500.0010.3223.8374.7016.1324.9620.26
    6.3BBLACKBIO1145.5517.71983.190.448.98-28.9933.4950.5926.0325.45
    7.GKB63.959.9432.230.001.85387.9933.042.268.827.97
    Detailed Comparison with:

    Quarterly Results

    Consolidated Figures in Rs. Crores / View Standalone

    No quarterly results found

    We don't have this information yet. Please check back later.

    Profit & Loss

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    183
    149
    Operating Profit
    36
    OPM %
    20
    Other Income
    2
    Interest
    4
    Depreciation
    2
    30
    Tax %
    28
    Net Profit
    21
    EPS
    20
    Dividend Payout %
    0
    Minority Interest
    0
    Share of Associates
    11
    Adjusted EPS
    20
    Minority Interest
    0
    Share of Associates
    11
    Adjusted EPS
    20
    Mar 2024
    204
    166
    Operating Profit
    41
    OPM %
    20
    Other Income
    3
    Interest
    6
    Depreciation
    4
    31
    Tax %
    29
    Net Profit
    22
    EPS
    219
    Dividend Payout %
    0
    Minority Interest
    0
    Share of Associates
    13
    Adjusted EPS
    22
    Minority Interest
    0
    Share of Associates
    13
    Adjusted EPS
    22
    Mar 2025
    314
    239
    Operating Profit
    83
    OPM %
    27
    Other Income
    9
    Interest
    15
    Depreciation
    7
    44
    Tax %
    45
    Net Profit
    25
    EPS
    179
    Dividend Payout %
    0
    Minority Interest
    0
    Share of Associates
    4
    Adjusted EPS
    18
    Minority Interest
    0
    Share of Associates
    4
    Adjusted EPS
    18

    COMPOUNDED SALES GROWTH

    10 Years:
    —
    5 Years:
    —
    3 Years:
    —

    COMPOUNDED PROFIT GROWTH

    10 Years:
    —
    5 Years:
    —
    3 Years:
    —

    STOCK PRICE CAGR

    10 Years:
    —
    5 Years:
    —
    3 Years:
    —
    1 Year:
    —

    RETURN ON EQUITY

    10 Years:
    —
    5 Years:
    —
    3 Years:
    15%
    Last Year:
    14%

    Balance Sheet

    Consolidated Figures in Rs. Crores / View Standalone

    Corporate actions

    No bonus data found

    Mar 2023
    Equity Capital
    2
    126
    54
    Trade Payables
    40
    30
    Total Liabilities
    251
    23
    Capital Work in Progress
    12
    16
    44
    0
    Cash & Bank
    90
    67
    Total Assets
    251
    Total Debt
    74
    Net Working Capital
    68
    Contingent Liabilities
    0
    Book Value per Share
    808.67
    Face Value
    10.00
    Total Debt
    74
    Net Working Capital
    68
    Contingent Liabilities
    0
    Book Value per Share
    808.67
    Face Value
    10.00
    Mar 2024
    Equity Capital
    2
    160
    50
    Trade Payables
    59
    67
    Total Liabilities
    339
    60
    Capital Work in Progress
    19
    29
    105
    26
    Cash & Bank
    30
    69
    Total Assets
    339
    Total Debt
    97
    Net Working Capital
    58
    Contingent Liabilities
    0
    Book Value per Share
    1027.39
    Face Value
    10.00
    Total Debt
    97
    Net Working Capital
    58
    Contingent Liabilities
    0
    Book Value per Share
    1027.39
    Face Value
    10.00
    Mar 2025
    Equity Capital
    2
    188
    57
    Trade Payables
    56
    152
    Total Liabilities
    455
    74
    Capital Work in Progress
    59
    18
    90
    83
    Cash & Bank
    47
    84
    Total Assets
    455
    Total Debt
    166
    Net Working Capital
    85
    Contingent Liabilities
    0
    Book Value per Share
    1206.00
    Face Value
    10.00
    Total Debt
    166
    Net Working Capital
    85
    Contingent Liabilities
    0
    Book Value per Share
    1206.00
    Face Value
    10.00

    Cash Flows

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    25
    Cash from Investing
    -26
    Cash from Financing
    26
    25
    Free Cash Flow
    25
    OCF / Net Profit
    1.17
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    1.17
    Cumulative 5-Year FCF
    0
    Mar 2024
    -24
    Cash from Investing
    -45
    Cash from Financing
    17
    -52
    Free Cash Flow
    -73
    OCF / Net Profit
    -1.12
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    -1.12
    Cumulative 5-Year FCF
    0
    Mar 2025
    -1
    Cash from Investing
    -59
    Cash from Financing
    53
    -7
    Free Cash Flow
    -62
    OCF / Net Profit
    -0.05
    Cumulative 5-Year FCF
    0
    OCF / Net Profit
    -0.05
    Cumulative 5-Year FCF
    0

    Ratios

    Consolidated Figures in Rs. Crores / View Standalone

    Mar 2023
    EPS (₹)
    203.79
    Book Value (₹)
    808.67
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    14.93
    Operating Margin %
    19.61%
    Net Margin %
    11.70%
    ROE %
    16.79%
    ROCE %
    16.76%
    8.52%
    Debtor Days
    66
    Inventory Days
    87
    Payable Days
    164
    -11
    Debt to Equity (x)
    0.58x
    Interest Coverage (x)
    8.75x
    1.63x
    Revenue Growth %
    0.00%
    Operating Profit Growth %
    0.00%
    Net Profit Growth %
    0.00%
    0.00%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    0.00x
    Mar 2024
    EPS (₹)
    218.73
    Book Value (₹)
    1027.39
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    16.23
    Operating Margin %
    18.69%
    Net Margin %
    10.63%
    ROE %
    14.97%
    ROCE %
    16.07%
    7.34%
    Debtor Days
    53
    Inventory Days
    133
    Payable Days
    194
    -7
    Debt to Equity (x)
    0.60x
    Interest Coverage (x)
    5.83x
    1.42x
    Revenue Growth %
    11.44%
    Operating Profit Growth %
    14.06%
    Net Profit Growth %
    1.21%
    7.33%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    1.68x
    Mar 2025
    EPS (₹)
    178.61
    Book Value (₹)
    1206.00
    Dividend per Share (₹)
    0.00
    Cash EPS (₹)
    20.21
    Operating Margin %
    23.74%
    Net Margin %
    7.81%
    ROE %
    13.94%
    ROCE %
    19.19%
    6.18%
    Debtor Days
    63
    Inventory Days
    114
    Payable Days
    144
    33
    Debt to Equity (x)
    0.88x
    Interest Coverage (x)
    3.98x
    1.48x
    Revenue Growth %
    54.08%
    Operating Profit Growth %
    103.82%
    Net Profit Growth %
    13.27%
    -18.34%
    P/E (x)
    0.00x
    P/B (x)
    0.00x
    Dividend Yield %
    0.00%
    1.45x

    Shareholding Pattern

    Numbers in percentages

    TRADES

    No quarterly shareholding data found

    We don't have this information yet. Please check back later.

    Documents

    Announcements

    Nothing filed yet.

    Annual Reports

    Nothing filed yet.

    Credit Ratings

    Nothing filed yet.

    Concalls